| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ceo-the Americas | Chief Operating Officer | Grp Chief Exec-com, Med &Tech
1 company
Walsh John F serves as a Ceo-the Americas at ACN. Across recent SEC filings that breaks down to 0 buys and 28 sells. Those positions are worth an estimated $5.2M at current prices.
Historically, Walsh John F's trades have earned a middling insider score of 65/100 across 5 rated trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +18.4%.
The biggest single holding is ACN (~$5.2M) as Ceo-the Americas. The recent filings there lean toward selling, a net 30,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | ACN Accenture Plc | Ceo-the Americas | Sell | 14 | $242.04 | $3,388.59 | - | - | - | |
| Jan 27, 2026 | ACN Accenture Plc | Ceo-the Americas | Sell | 3,986 | $276.38 | $1,101,644.48 | -12.8% | - | - | |
| May 13, 2025 | ACN Accenture Plc | Chief Operating Officer | Sell | 2,500 | $325.00 | $812,500.00 | -13.6% | -26.0% | -50.5% | |
| Jan 23, 2025 | ACN Accenture Plc | Chief Operating Officer | Sell | 2,500 | $361.09 | $902,719.70 | -11.2% | -20.7% | -22.6% | |
| Oct 17, 2024 | ACN Accenture Plc | Chief Operating Officer | Sell | 5,000 | $373.24 | $1,866,218.50 | -22.1% | -6.8% | -36.5% | |
| Mar 25, 2024 | ACN Accenture Plc | Chief Operating Officer | Sell | 8,000 | $332.13 | $2,657,033.96 | -30.9% | -8.0% | -7.5% | |
| Oct 24, 2023 | ACN Accenture Plc | Chief Operating Officer | Sell | 2,500 | $295.60 | $738,988.22 | -10.3% | +24.0% | +25.2% | |
| Jan 21, 2020 | ACN Accenture Plc | Grp Chief Exec-com, Med &Tech | Sell | 6,000 | $209.21 | $1,255,267.28 | -22.6% | - | - |